Bone marrow-derived stem cells and hepatocarcinogenesis in hepatitis B virus transgenic mice

Digestive and Liver Disease

Volumn 46, Issue 3, 2014, Pages 243-250

  Barone, Michele ^a   Scavo, Maria Principia ^a   Maiorano, Eugenio ^a   Di Leo, Alfredo ^a   Francavilla, Antonio ^b  

^a UNIVERSITY OF BARI   (Italy)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

Cell fusion; Cell homing; Cell mimicry; Microenvironment

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATOCYTE NUCLEAR FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW DERIVED STEM CELL; BONE MARROW TRANSPLANTATION; CELL COUNTING; CELL SUSPENSION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC SUSCEPTIBILITY; HEPATITIS B; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; TRANSGENIC MOUSE; Y CHROMOSOME;

CELL FUSION; CELL HOMING; CELL MIMICRY; MICROENVIRONMENT;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATOCYTES; IN SITU HYBRIDIZATION, FLUORESCENCE; LIVER NEOPLASMS; MALE; MICE; MICE, TRANSGENIC; STEM CELLS; Y CHROMOSOME;

EID: 84893780410     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2013.10.008     Document Type: Article

References (45)

1. Sell S. Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology 2001, 33:738-750.
2. Shafritz D.A., Dabeva M.D. Liver stem cells and model systems for liver repopulation. J Hepatol 2002, 36:552-564.
3. Gordon G.J., Coleman W.B., Grisham J.W. Temporal analysis of hepatocyte differentiation by small hepatocyte-like progenitor cells during liver regeneration in retrorsine-exposed rats. Am J Pathol 2000, 157:771-786.
4. Yin L., Sun M., Ilic Z., et al. Derivation, characterization, and phenotypic variation of hepatic progenitor cell lines isolated from adult rats. Hepatology 2002, 35:315-324.
5. Lagasse E., Connors H., Al-Dhalimy M., et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000, 6:1229-1234.
6. Wang X., Montini E., Al-Dhalimy M., et al. Kinetics of liver repopulation after bone marrow transplantation. Am J Pathol 2002, 161:565-574.
7. Reya T., Morrison S.J., Clarke M.F., et al. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
8. Hemmati H.D., Nakano I., Lazareff J.A., et al. Cancerous stem cells can arise from pediatric brain tumours. Proc Natl Acad Sci U S A 2003, 100:15178-15183.
9. Chiba T., Kita K., Zheng Y.W., et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 2006, 44:23-26.
10. Ma S., Chan K.W., Hu L., et al. Identification and characterization of tumourigenic liver cancer stem/progenitor cells. Gastroenterology 2007, 132:2542-2556.
11. Chisari F.V., Pinkert C.A., Milich D.R., et al. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science 1985, 230:1157-1160.
12. Chisari F.V., Filippi P., Buras J., et al. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci USA 1987, 84:6909-6913.
13. Dunsford H.A., Sell S., Chisari F.V. Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice. Cancer Res 1990, 50:3400-3407.
14. Chisari F.V., Klopchin K., Moriyama T., et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989, 59:1145-1156.
15. Huang S.N., Chisari F.V. Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice. Hepatology 1995, 21:620-626.
16. Barone M., Maiorano E., Ladisa R., et al. Influence of ursodeoxycholate-enriched diet on liver tumour growth in HBV transgenic mice. Hepatology 2003, 37:880-886.
17. Crawford D.R., Ostrowski S., Vakharia D., et al. Separate origins of hepatitis B virus surface antigen-negative foci and hepatocellular carcinomas in transgenic HBsAg (alb/psx) mice. Am J Pathol 2006, 169:223-232.
18. Swenson E.S., Guest I., Ilic Z., et al. Hepatocyte nuclear factor-1 as marker of epithelial phenotype reveals marrow-derived hepatocytes, but not duct cells, after liver injury in mice. Stem Cells 2008, 26:1768-1777.
19. Lokmane L., Haumaitre C., Garcia-Villalba P., et al. Crucial role of vHNF1 in vertebrate hepatic specification. Development 2008, 135:2777-2786.
20. Theise N.D., Badve S., Saxena R., et al. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 2000, 31:235-240.
21. Krause D.S., Theise N.D., Collector M.I., et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001, 105:369-377.
22. Cogle C.R., Theise N.D., Fu D., et al. Bone marrow contributes to epithelial cancers in mice and humans as developmental mimicry. Stem Cells 2007, 25:1881-1887.
23. Ishikawa H., Nakao K., Matsumoto K., et al. Bone marrow engraftment in a rodent model of chemical carcinogenesis but no role in the histogenesis of hepatocellular carcinoma. Gut 2004, 53:884-889.
24. Lin H.J., Wu P.C., Lai C.L. An oligonucleotide probe for the detection of hepatitis B virus DNA in serum. J Virol Methods 1987, 15:139-149.
25. Ponti D., Costa A., Zaffaroni N., et al. Isolation and in vitro propagation of tumourigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005, 65:5506-5511.
26. Patrawala L., Calhoun T., Schneider-Broussard R., et al. Highly purified CD44+ prostate cancer cells from xenograft human tumours are enriched in tumourigenic and metastatic progenitor cells. Oncogene 2006, 25:1696-1698.
27. Kim C.F., Jackson E.L., Woolfenden A.E., et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005, 121:823-835.
28. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115.
29. Houghton J., Stoicov C., Nomura S., et al. Gastric cancer originating from bone marrow-derived cells. Science 2004, 306:1568-1571.
30. Avital I., Moreira A.L., Klimstra D.S., et al. Donor-derived human bone marrow cells contribute to solid organ cancers developing after bone marrow transplantation. Stem Cells 2007, 25:2903-2909.
31. Newsome P.N., Johannessen I., Boyle S., et al. Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusion. Gastroenterology 2003, 124:1891-1900.
32. Vassilopoulos G., Wang P.R., Russell D.W. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003, 422:901-904.
33. Wang X., Willenbring H., Akkari Y., et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003, 422:897-901.
34. Shackel N.A., Rockey D.C. Stem cells and liver disease: promise laced with confusion and intrigue. Gastroenterology 2004, 127:346-348.
35. Thorgeirsson S.S., Grisham J.W. Hematopoietic cells as hepatocyte stem cells: a critical review of the evidence. Hepatology 2006, 43:2-8.
36. Dalakas E., Newsome P.N., Harrison D.J., et al. Hematopoietic stem cell trafficking in liver injury. FASEB J 2005, 19:1225-1231.
37. Piscaglia A.C., Shupe T.D., Oh S.H., et al. Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats. Gastroenterology 2007, 133:619-631.
38. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357:539-545.
39. Mantovani A., Balkwill F. RalB signaling: a bridge between inflammation and cancer. Cell 2006, 127:42-44.
40. Karin M., Greten F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005, 5:749-759.
41. Pikarsky E., Porat R.M., Stein I., et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004, 431:461-466.
42. Sakurai T., Maeda S., Chang L., et al. Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. Proc Natl Acad Sci U S A 2006, 103:10544-10551.
43. Barone M., Maiorano E., Scavo M.P., et al. Effect of gonadectomy on HCC development in HBV transgenic mice. Dig Liver Dis 2009, 41:150-155.
44. Masson S., Harrison D.J., Plevris J.N., et al. Potential of hematopoientic stem cell therapy in hepatology: a critical review. Stem Cells 2004, 22:897-907.
45. Allison M.R., Lovell M.J. Liver cancer: the role of stem cells. Cell Prolif 2005, 38:407-421.